Table 3 Evaluation of the process of rapid guidelines’ development and the quality of reporting applying the AGREE II according to organisationsa
From: Development of rapid guidelines: 1. Systematic survey of current practices and methods
AGREE II domain | WHO (n = 8) | NICE (n = 9) | CDC (n = 17) | Othersb (n = 12) |
|---|---|---|---|---|
Scoping and purpose | 81% (67–97%) | 94% (83–97%) | 69% (53–97%) | 67% (22–89%) |
Stakeholder involvement | 72% (67–81%) | 92% (86–100%) | 32% (6–69%) | 33% (6–67%) |
Rigor of development | 71% (57–84%) | 91% (88–95%) | 10% (0–34%) | 36% (5–75%) |
Clarity of presentation | 92% (81–97%) | 93% (89–100%) | 82% (61–100%) | 83% (21–97%) |
Applicability | 54% (44–60%) | 89% (42–92%) | 25% (0–44%) | 21% (4–67%) |
Editorial independence | 83% (75–96%) | 81% (63–100%) | 19% (0–25%) | 25% (0–67%) |
Quality (1–7) | 6 (5–6.5 | 6 (4.5–6.5) | 4.5 (3.5–5) | 5 (2.5–5) |